Rottenstein Law Group Keeping an Eye on Zimmer Holdings’ Internal Restructuring

(New York, NY, April 18, 2011) The Rottenstein Law Group, which represents clients with claims stemming from the failures of defective knee replacement devices manufactured and sold by Zimmer Holdings, Inc., is keeping an eye on the internal restructuring of the company.
According to a statement released in March, Zimmer “implemented a number of organizational changes as part of the company’s transformation initiatives to accelerate growth and customer focus.”
“These changes resulted in the elimination of certain positions across the company’s businesses and operating locations. All affected employees will be supported with a range of severance and outplacement benefits. As Zimmer continues its transformative programs, the company expects recent personnel reductions to be more than offset by future hiring.”
According to the Austin Business Journal, Zimmer reported net sales of $1.13 billion in the fourth quarter of 2010, an increase of 2.5 percent over the previous year; notwithstanding recent difficulties with the company’s NexGen CR-Flex replacement knee systems.
In 2003, the Zimmer NexGen CR-Flex implant was introduced as the latest solution to common knee problems. The product promised to give recipients a broader range of motion than had been delivered by previous knee replacement devices. The CR-Flex implants have been used in over 150,000 procedures, making Zimmer millions of dollars in yearly revenue. A recent study brought to light data that is questioning the effectiveness of the NexGen CR-Flex devices. The surgeons who authored the study are advocating for the product’s removal from the market.
The “cementless” version of the Zimmer NexGen CR-Flex device is leading to the reported problems in patients. Most knee replacement systems are attached to the thigh bone with a type of cement, but the NexGen device is supposed to attach to the bone through natural ingrowth. This is an excellent medical advancement in theory, but in practice, the device has been loosening in recipients, causing serious pain and difficulty walking. So far, there has been no word from Zimmer or the U.S. Food and Drug Administration regarding the possibility of a recall, but victims are currently investigating their legal options, including the possibility of filing Zimmer replacement knee lawsuits.
Unfortunately, recipients of joint replacement devices are not normally told which devices they are being implanted with. This circumstance can lead to a victim failing to take the appropriate action when faced with subsequent difficulties. The Rottenstein Law Group is encouraging anyone with a friend or relative who has had a knee replacement to recommend that he or she speak to a physician immediately, and then speak to a qualified personal injury lawyer. The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations.
The Rottenstein Law Group maintains a Zimmer Knee Replacement Lawsuit Information Center which is equipped with social media features that will enable users to spread the word about DePuy Pinnacle hip replacement device failures.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.

Contact Information

Nava Brahe

PR Manager

The Rottenstein Law Group

Contact via E-mail